CAS 1382979-44-3

Formula: C18H22N8O2

InChI: InChI=1S/C18H22N8O2/c1-18(2)16-22-12-14(25-3-6-27-7-4-25)23-13(11-9-20-17(19)21-10-11)24-15(12)26(16)5-8-28-18/h9-10H,3-8H2,1-2H3,(H2,19,20,21)

InChI key: LGWACEZVCMBSKW-UHFFFAOYSA-N

SMILES: CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C

GDC0084

CAS: 1382979-44-3

GDC0084

Formula: C₁₈H₂₂N₈O₂

Purity: ≥95%

Color and Shape: Solid

Molecular weight: 382.42

Ref: 54-BUP13043

GDC0084

CAS: 1382979-44-3

GDC0084 (RG7666) is a PI3K inhibitor with potential antineoplastic activity.

Formula: C₁₈H₂₂N₈O₂

Purity: 99.26% - 99.87%

Color and Shape: White Solid

Molecular weight: 382.4197

Ref: TM-T3705

GDC-0084

CAS: 1382979-44-3

5-(6,6-Dimethyl-4-morpholino-8,9-dihydro-6H-[1,4]oxazino[4,3-e]purin-2-yl)pyrimidin-2-amine

Formula: C₁₈H₂₂N₈O₂

Purity: 95%

Molecular weight: 382.42

Ref: IN-DG630205

Paxalisib

CAS: 1382979-44-3

Purity: 95%

Molecular weight: 382.187

Ref: 10-F861800

GDC 0084

CAS: 1382979-44-3

PI3K and mTOR enzyme inhibitor; anti-cancer agent

Formula: C₁₈H₂₂N₈O₂

Purity: Min. 95%

Molecular weight: 382.42 g/mol

Ref: 3D-FD145121

2-​Pyrimidinamine, 5-​[8,​9-​dihydro-​6,​6-​dimethyl-​4-​(4-​morpholinyl)​-​6H-​[1,​4]​oxazino[4,​3-​e]​purin-​2-​yl]​-

CAS: 1382979-44-3

Formula: C₁₈H₂₂N₈O₂

Purity: 95%

Color and Shape: Solid

Molecular weight: 382.4197

Ref: IN-DA0018GR